Business · 07/03/2023
FDA Clears Lithium Citrate Oral Solution for Sale
The US Food and Drug Administration (FDA) has ruled that lithium citrate oral solution, 8 milliequivalents/5 milliliters, was not withdrawn from sale due to safety or effectiveness concerns, allowing the drug to remain on the market.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →